SB27 ensures that pharmaceutical manufactures comply with the federal 340B Drug Pricing Program.

The Senate passed SB27 on March 8, 2024, by a vote of 32 to 5. We have assigned pluses to the nays because Section 340B of the Public Health Service Act, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices, is unconstitutional. Medicaid, not to mention the U.S. Department of Health and Human Services, is not authorized under Article I, Section 8, of the Constitution, as neither health care nor social welfare is the legitimate object of government. Government-subsidized health care or drug pricing, not to mention the “benefits” provided to illegal aliens, are financed by immoral and anti-constitutional forms of taxation (e.g., personal or corporate income taxes) that violate the Bill of Rights and the 14th Amendment by taking from citizens the wages they have rightfully earned. The General Assembly should act instead to nullify all unconstitutional federal laws and end reckless economic incentives.  

Learn More